

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.461, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


US FDA finds no mortality increase with cefepime
Reactions Weekly, Vol. 1, Iss. 1258, 2009-01 ,pp. :


The Case for Less, Not More, US FDA Regulation
By Vernon John A. Golec Joseph H.
PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. :


US generics a better bet than off-shore branded drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 553, 2008-01 ,pp. :


Canadians with low income enjoy better health than US counterparts
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :